Kopran Limited
NSE: KOPRAN.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Surendra Shrikrishna Somani
- Employees
- 842
- Headquarters
- Mumbai, India
- IPO year
- 2002
- Market cap
- ₹7.8B
- Website
- https://www.kopran.com
Loading KOPRAN…
Loading profile data…Frequently asked questions about KOPRAN
What does Kopran Limited (KOPRAN.NS) do?
Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, dry powder, suspension, and injectables. It also provides active pharmaceutical ingredients in...
Where does KOPRAN.NS trade?
Kopran Limited (KOPRAN.NS) trades on the National Stock Exchange of India.
What sector is KOPRAN.NS in?
Kopran Limited (KOPRAN.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Kopran Limited?
Surendra Shrikrishna Somani is the chief executive officer of Kopran Limited (KOPRAN.NS).
Where is Kopran Limited headquartered?
Kopran Limited is headquartered in India.
Does KOPRAN.NS pay a dividend?
Yes — Kopran Limited (KOPRAN.NS) paid a trailing twelve-month dividend of INR 3.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did KOPRAN.NS go public?
Kopran Limited (KOPRAN.NS) completed its initial public offering in 2002.